Reprogramming psychiatry: stem cells and bipolar disorder

Lancet. 2016 Feb 27;387(10021):823-5. doi: 10.1016/S0140-6736(16)00235-X. Epub 2016 Feb 26.

Authors

Paul J Harrison¹, M Zameel Cader², John R Geddes³

Affiliations

¹ Department of Psychiatry, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford OX3 7JX, UK.
² Weatherall Institute of Molecular Medicine, Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, UK.
³ Department of Psychiatry, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford OX3 7JX, UK. Electronic address: john.geddes@psych.ox.ac.uk.

PMID: 26972063
DOI: 10.1016/S0140-6736(16)00235-X

No abstract available

Publication types

Comment

MeSH terms

Action Potentials / drug effects*
Antipsychotic Agents / pharmacology*
Bipolar Disorder / pathology*
Humans
Lithium Compounds / pharmacology*
Male
Neurons / drug effects*
Neurons / pathology*

Substances

Antipsychotic Agents
Lithium Compounds